977 related articles for article (PubMed ID: 17894887)
1. OncomiRs: the discovery and progress of microRNAs in cancers.
Cho WC
Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and function in cancer.
Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS; Dutta A
Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
[TBL] [Abstract][Full Text] [Related]
4. The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N; Maher SG; Reynolds JV
Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
[TBL] [Abstract][Full Text] [Related]
5. miRNAs in cancer: approaches, aetiology, diagnostics and therapy.
Blenkiron C; Miska EA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R106-13. PubMed ID: 17613543
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R; Hussey DJ; Haier J
Eur J Cancer; 2010 Jan; 46(2):298-311. PubMed ID: 19948396
[TBL] [Abstract][Full Text] [Related]
7. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
Tong AW; Nemunaitis J
Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs and cancer.
Cowland JB; Hother C; Grønbaek K
APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells.
Takakura S; Mitsutake N; Nakashima M; Namba H; Saenko VA; Rogounovitch TI; Nakazawa Y; Hayashi T; Ohtsuru A; Yamashita S
Cancer Sci; 2008 Jun; 99(6):1147-54. PubMed ID: 18429962
[TBL] [Abstract][Full Text] [Related]
10. The role of microRNAs in normal and malignant hematopoiesis.
Vasilatou D; Papageorgiou S; Pappa V; Papageorgiou E; Dervenoulas J
Eur J Haematol; 2010 Jan; 84(1):1-16. PubMed ID: 19744129
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ
Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA function in cancer: oncogene or a tumor suppressor?
Shenouda SK; Alahari SK
Cancer Metastasis Rev; 2009 Dec; 28(3-4):369-78. PubMed ID: 20012925
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
Welch C; Chen Y; Stallings RL
Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs and cancer.
Wijnhoven BP; Michael MZ; Watson DI
Br J Surg; 2007 Jan; 94(1):23-30. PubMed ID: 17205498
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in human cancer: from research to therapy.
Negrini M; Ferracin M; Sabbioni S; Croce CM
J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
Metias SM; Lianidou E; Yousef GM
J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]